New study to use ultrasound to improve radiotherapy for most common form of brain tumour
The work will explore how ultrasound can be combined with small gas-filled bubbles – microbubbles – to improve the effectiveness of radiotherapy
Low-grade tumours are not low impact, and while the majority of meningioma tumours are slow growing, symptoms and the side effects of treatment can be devastating.
Professor David Parkinson
Director of the Brain Tumour Research Centre
We need to think outside the box; we need to be braver if we are going to change things for brain tumour patients. We wanted to invest in this project because focused ultrasound really feels like it could change the landscape for so many cancers. We’ve seen first-hand the debilitating consequences of harsh and blunt treatments such as radiotherapy, but currently it’s one of the only tools available for many brain tumour types, so anything that can be done to make it more effective is vital.
Meningioma is the most common primary brain tumour in the UK, but for many patients requiring radiotherapy, the approach is harsh and not very effective. We are focused on the development of new approaches to improve outcomes for people affected by brain tumours and we hope this innovative new study can open up avenues for improving the impact of radiotherapy. We are striving towards a future where a brain tumour diagnosis is no longer defined by uncertainty, distress and limited options, but where patients have hope, personalised care pathways and a realistic expectation that they will get better.